Disposal of Shares & Repayment of Loan Stock

 

TIDMHCEG 
 
RNS Number : 2378Q 
Healthcare Enterprise Group PLC 
07 April 2009 
 
Healthcare Enterprise Group plc 
("HCEG", "the Company" or "the Group") 
Disposal of shares in First Aid Holdings Limited, transfer of shares in Ebiox 
Limited, and repayment in full of secured loan stock. 
Healthcare Enterprise Group plc (AIM: HCEG) announces that on 7 April 2009 it 
transferred 303,689 shares in First Aid Holdings Limited ("FAH")  to the holders 
of secured loan stock in the Company to redeem GBP350,000 of the outstanding 
secured loan stock plus accrued interest. Following this disposal the Company's 
holding in FAH will reduce from 24.9% to 11.2%. Simultaneously, the Company 
 transferred  162,690 ordinary shares in Ebiox Ltd to secured loan stock holders 
to satisfy the balance of the secured loan stock of GBP150,000 and accured 
interest thereon. Following this disposal the Company's holding in Ebiox Ltd 
will reduce from 100% to 95.1%. As a result of these transactions, the Company 
will not have any secured borrowings. 
Under the AIM Rules, John Gunn (Non-Executive Director) a secured loan stock 
holder is classified as a related party. Lyndon Gaborit (Executive Deputy 
Chairman) considers, having consulted with Daniel Stewart (the Company's 
Nominated Adviser), that the terms of loans are fair and reasonable insofar as 
its shareholders are concerned. 
Pursuant to the announcement made on 22 December 2008, the Company's shares 
remain suspended from trading on AIM. 
 
 
Further Enquiries: 
Healthcare Enterprise Group Plc 
Lyndon Gaborit, Executive Deputy Chairman Tel: + 44 (0)1925 898 200 
www.hcegroup.com 
Daniel Stewart & Company Plc 
Lindsay Mair/Stewart Dick  Tel: + 44 (0) 207 776 6550 
 
 Notes to Editors: 
Healthcare Enterprise Group PLC companies include Ebiox Limited, a specialist 
disinfectant and decontamination company which has a range of proprietary 
products patented and approved for sale in multiple world markets; Reproductive 
Sciences Limited which invests in medical devices product development, 
particularly in the area of women's' health; and investments in healthcare 
products and services. 
FAH and its subsidaries, which are independently owned, are engaged in the sale 
of first aid and healthcare related products. 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 MSCILFLDSAIRIIA